A paradigm shift in women’s cardiovascular (CV) care is required. This Female Life Stage framework provides a unifying, person centered approach across the life course beginning with menarche and through the years after menopause to optimize CV health for all girls, women, and their communities. Physiologic changes in sex hormones define clinically distinct life stages: perimenarche, ovarian cycling, perimenopause, postmenopause, each informing female-specific screening, prevention, and management. The peripregnancy period and exposure to exogenous hormone therapy can be considered as cross-cutting modifiers. Premenarche does not have sex-specific guidance for CV health, but is a foundational period to long-term CV health with CV health behaviors and attitudes being developed early. @American_Heart, @AmerAcadPeds, @acog and the Society for Maternal-Fetal Medicine jointly approve this shared model. 📷 Interconnected hormonal, psychosocial, and cardiovascular health across the female life course. ✍🏼 @heartDocSadiya professional.heart.org/en/sc…